Update {#Sec1}
======

This update relates to the CopenHeart~VR~ trial study protocol, a randomized clinical trial comparing comprehensive cardiac rehabilitation after heart valve surgery, including physical exercise and psycho-education, with usual care. This update should be read in conjunction with the original protocol publication \[[@CR1]\].

Revised trial population {#Sec2}
------------------------

The plan for this trial was to include patients having either open heart surgery or percutaneous heart valve procedures. However, because of administrative reasons and other local ongoing clinical trials including patients having percutaneous procedures, we were only able to include patients having open heart surgery.

Statistical analysis plan {#Sec3}
-------------------------

### Updated sample size and power {#Sec4}

Our original recruitment target was 210 with the recruitment period defined as two years. At the end of the two-year recruitment period in May 2014, we were only able to include 147 patients. Therefore, the power calculation has been repeated, based on this revised sample size.

The primary outcome is the continuous variable peak oxygen uptake (VO~2~ peak) measured by cardiopulmonary exercise testing. Based on the assumptions defined in the protocol (a minimum clinical meaningful difference of 3 mL/kg/min and standard deviation of 6 ml/kg/min), a sample size of 147 would provide 86% power to be able to reject the null hypothesis, with a type I error of 5%. The secondary outcome measure is mental health measured on the continuous variable mental health component scale on the Short Form-36 questionnaire. Based on the assumed minimum important difference of seven points and an updated standard deviation of nine points \[[@CR2]\], we will be able to reject the null hypothesis with a probability of 99% and a type I error probability of 5%.

Statistical analysis plan for the primary and secondary outcomes {#Sec5}
----------------------------------------------------------------

While the primary analysis essentially remains the same as defined in the protocol, we propose slight revisions to the analysis model and handling of missing data, and also provide further specification of the handling of multiplicity of outcome testing.

### Primary analysis {#Sec6}

The level of significance is set at 5%. The intention-to-treat analysis using a mixed model with repeated measures (MMRM) for continuous outcome measures will be adjusted by the trial stratification variable 'left ventricular ejection fraction \<45%, yes/no' \[[@CR3]\].

### Missing values and sensitivity analyses {#Sec7}

As stated in the protocol, using MMRM ensures that missing data values will not create bias, as long as the values are missing at random \[[@CR4]\]. For the primary and secondary outcomes, if a statistically significant result is obtained (*P* ≤0.05), we will undertake sensitivity analyses that use the method of multiple imputation \[[@CR5],[@CR6]\] and also undertake imputation that assumes not missing at random and includes 'worst-case' and 'best-case' scenarios.

### Multiplicity {#Sec8}

The primary and secondary outcomes (VO~2~ peak and mental health component scale of Short Form-36) will be analyzed as stated above. The various exploratory outcome measures pre-defined in the protocol \[[@CR1]\] will be analyzed with no adjustment of *P*-values due to multiplicity. Instead, the interpretation of each exploratory outcome measure will be assessed in the light of multiple testing; that is, statistically significant effects will be interpreted in the context of increased risk of type I error.

Per-protocol analysis {#Sec9}
---------------------

In addition to the primary analysis, we will also undertake a per-protocol analysis to account for the variable adherence to the prescribed rehabilitation program by intervention group participants \[[@CR7]\]. We expect that the effect of the intervention will depend on the participants' adherence to the study protocol \[[@CR8]\].

The per-protocol definition is based on the intervention consisting of two elements: physical exercise and a psycho-educational intervention. Adherence to both elements of the intervention will be described according to compliance data for self-reported training diaries, data from pulse watches, and records made in relation to the nurse consultations.

Physical exercise {#Sec10}
-----------------

The physical exercise comprises three weekly sessions conducted between one and four months after surgery, a total of 36 sessions. Participation in the intervention will be defined as participation in an individual consultation to plan exercise training, receiving instruction in the use of the training diary and pulse watch, and participation in 75% (≥27) of the exercise sessions.

Psycho-educational intervention {#Sec11}
-------------------------------

The psycho-educational intervention is based on the theories of RR Parse \[[@CR9]\] and comprises one monthly consultation conducted within the first six months after surgery, a total of five consultations. Participation in the intervention will be defined as attending at least 80% (four out of five) of the psycho-educational consultations.

Ethical approval {#Sec12}
----------------

The study was approved by the regional Danish Research Ethics Committee in the Capital Region of Denmark (H-1-2011-157) and the Danish Data Protection Agency (j.nr. 2007-58-0015). All participants have given full written and oral informed consent.
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